Purple BiotechPPBT
13F holders, Q3 2025 (September 30)3holders +1
1new positions
0sold out
$0.58avg. 13F price*
At the end of Q3 2025, 3 institutions reported holding Purple Biotech Ltd. (PPBT) in their 13F filings, up 1 from Q2 2025. 1 opened new positions and 0 sold out. The largest holders were Advisory Services Network, LLC ($57), EverSource Wealth Advisors, LLC ($32) and North Star Investment Management Corp. ($9).
- Company
- Purple Biotech Ltd.
- CUSIP
- 74638P109
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $57 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 139 shares bought, net +139 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| Advisory Services Network, LLC | 0.00% | New | 99 | $57 |
| EverSource Wealth Advisors, LLC | 0.00% | Add +250.0% | 56 | $32 |
| North Star Investment Management Corp. | 0.00% | No change | 15 | $9 |
"% of holder's portfolio" is PPBT's weight in each manager's 13F, not the share of Purple Biotech Ltd. the manager owns.